Cronos (CRON) financial statements

Healthcare · Drug Manufacturers - Specialty & Generic · Market cap $1.2B

Cronos reported revenue of $147M in fiscal 2025, up 61.6% a year over 8 years.

Net income was -$9M and the operating margin -11.9%, against -194.5% in 2017.

Free cash flow was $149,000, and the company returned $10M in net buybacks.

The diluted share count rose 117% over the period (dilution).

Revenue and free cash flow

Fiscal years, $ billions.

-0.2-0.100.10.2201720182019202020212022202320242025RevenueFree cash flow
Embed this chart

Free to use in articles and newsletters with the source line. Paste this HTML:

Income statement

Fiscal years, from Cronos's 10-K filings with the SEC.

Fiscal year201720182019202020212022202320242025
Revenue$3M$12M$24M$47M$65M$87M$87M$118M$147M
Cost of revenue$2M$6M$12M$46M$70M$71M$75M$92M$83M
Gross profit$2M$6M-$18M-$26M-$18M$15M$12M$25M$63M
Research and development$0$2M$12M$20M$22M$13M$6M$4M$4M
Selling, general and admin$5M$16M$105M$115M$112M$86M$72M$68M$64M
Operating income-$6M-$20M-$153M-$219M-$292M-$111M-$85M-$77M-$17M
Interest expense$101,000$139,000$1M$186,000$27,000$13,000———
Pre-tax income-$2M-$21M$1.2B-$73M-$129M-$121M-$74M$37M-$17M
Income tax-$862,000$0$0$1M-$431,000$34M-$3M-$3M-$14M
Net income-$1M-$22M$1.2B-$73M-$396M-$169M-$74M$41M-$9M
EPS (diluted)-$0.01-$0.12$3.33-$0.21-$1.07-$0.45-$0.19$0.11-$0.02
Diluted shares177M172M343M352M370M377M381M386M383M
Gross margin50.0%51.3%-74.1%-55.3%-27.3%17.8%13.7%21.4%42.8%
Operating margin-194.5%-168.7%-645.5%-469.6%-452.2%-128.4%-97.2%-65.1%-11.9%
Net margin-47.1%-178.5%4911.6%-156.5%-613.5%-194.5%-84.8%34.9%-6.4%

Balance sheet

Fiscal years, from Cronos's 10-K filings with the SEC.

Fiscal year201720182019202020212022202320242025
Cash and short-term investments$7M$24M$1.5B$1.3B$1.0B$878M$862M$859M$832M
Receivables—$3M$5M$9M$22M$23M$14M$15M$34M
Inventory—$7M$38M$44M$33M$38M$30M$33M$47M
Total current assets—$40M$1.6B$1.4B$1.1B$960M$933M$936M$944M
Property, plant and equipment—$126M$160M$188M$74M$61M$59M$133M$146M
Goodwill$1M$1M$214M$180M$1M$1M$1M$63M$66M
Total assets—$183M$2.1B$1.9B$1.4B$1.2B$1.1B$1.2B$1.2B
Total current liabilities—$33M$333M$207M$54M$68M$41M$50M$48M
Total liabilities—$35M$341M$218M$63M$72M$44M$55M$54M
Shareholders' equity$64M$148M$1.7B$1.7B$1.3B$1.1B$1.1B$1.1B$1.1B
Net debt-$7M-$24M-$1.2B-$1.1B-$887M-$765M-$669M-$859M-$792M

Cash flow

Fiscal years, from Cronos's 10-K filings with the SEC.

Fiscal year201720182019202020212022202320242025
Operating cash flow-$4M-$8M-$131M-$145M-$154M-$89M-$43M$19M$26M
Capital spending$33M$88M$39M$31M$11M$3M$3M$12M$26M
Free cash flow-$37M-$96M-$170M-$176M-$165M-$92M-$45M$6M$149,000
Stock-based compensation$2M$8M$12M$15M$10M$15M$9M$9M$7M
Share buybacks (net)——————$0$0-$10M
Free cash flow margin-1182.2%-790.6%-715.2%-377.3%-255.2%-106.5%-52.0%5.5%0.1%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for CRON.
Open CRON in Investingly

Questions

What was Cronos's revenue in 2025?

$147M in fiscal 2025, from its 10-K filing.

How much free cash flow does Cronos generate?

$149,000 in fiscal 2025 (operating cash flow minus capital spending).

From Cronos's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.